Target intelligence / Profile preview

Rhodopsin (P23H mutant) messenger RNA (RHO-P23H mRNA) (RHO-P23H mRNA)

Target
RHO-P23H mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

P23H mutant rhodopsin mRNA is the messenger RNA transcript of the RHO gene containing a specific point mutation (c.68C>A) that results in a proline-to-histidine substitution at position 23 of the rhodopsin protein. This mutation is the most prevalent cause of autosomal dominant retinitis pigmentosa (adRP) in North America, accounting for approximately 10% of cases (Source: NIH, PubMed). The presence of this mutant mRNA leads to the production of a misfolded protein that accumulates in the endoplasmic reticulum, triggering the unfolded protein response and eventual apoptosis of rod photoreceptor cells (Source: UniProt). Therapeutic approaches targeting this mRNA focus on allele-specific silencing to selectively degrade the mutant transcript while preserving the wild-type mRNA necessary for vision. Antisense oligonucleotides (ASOs), such as QR-1123 (Ultevursen), are designed to bind to the mutant sequence and induce RNase H-mediated degradation (Source: ProQR Therapeutics). Successful targeting of this mRNA aims to reduce the proteotoxic stress in the retina and slow the progression of vision loss in affected patients.

Other names
P23H RHO mRNAMutant rhodopsin transcriptRHO P23H mRNAPro23His rhodopsin mRNARhodopsin P23H mutant transcript
02

Mechanism of action

Allele-specific knockdown of mutant mRNA via RNase H-mediated degradation or RNA interference (RNAi) to prevent the translation of misfolded rhodopsin protein.

03

Biological functions

Protein synthesisVisual phototransduction
04

Disease associations

Retinitis pigmentosaAutosomal dominant retinitis pigmentosa (adRP)
05

Safety considerations

Off-target knockdown of wild-type rhodopsin mRNARetinal inflammationIntravitreal delivery complicationsSustained expression requirements for long-term efficacy
06

Interacting drugs

QR-1123 (Ultevursen)

2 more in the full profile.

07

Biomarkers

Visual acuityOptical coherence tomography (OCT)Electroretinography (ERG)Ellipsoid zone (EZ) widthFundus autofluorescence

Beyond the preview

Go deeper on Rhodopsin (P23H mutant) messenger RNA (RHO-P23H mRNA) (RHO-P23H mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhodopsin (P23H mutant) messenger RNA (RHO-P23H mRNA) (RHO-P23H mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call